{"id":"W4380080925","doi":"10.1002/hon.3163_81","title":"ZANUBRUTINIB PLUS OBINUTUZUMAB VERSUS OBINUTUZUMAB IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA: UPDATED ANALYSIS OF THE ROSEWOOD STUDY","year":2023,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Jewish General Hospital","funders":"Seoul National University; Seoul National University Hospital; Institut National de la Santé et de la Recherche Médicale; Regeneron Pharmaceuticals; Cleveland Clinic","keywords":"Medicine; Obinutuzumab; Internal medicine; Follicular lymphoma; Rituximab; Refractory (planetary science); Oncology; International Prognostic Index; Clinical endpoint; Progression-free survival; Neutropenia; Salvage therapy; Gastroenterology; Surgery; Chemotherapy; Lymphoma; Randomized controlled trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007180771,0.0003508084,0.0018068,0.0006719651,0.0001213498,0.00001260101,0.000553465,0.0005073561,0.0003118039],"category_scores_gemma":[0.0009344119,0.0002021278,0.0003524945,0.005723584,0.0004970162,0.00006829642,0.0005409962,0.0004813336,0.0001084856],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.03895,"about_ca_system_score_gemma":0.0119755,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006570112,"about_ca_topic_score_gemma":0.0006458189,"domain_scores_codex":[0.9956257,0.00065045,0.0009490278,0.0007934068,0.001134926,0.0008464835],"domain_scores_gemma":[0.996877,0.001093564,0.0003609442,0.00114952,0.0002949955,0.0002240132],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.08490586,0.01424103,0.8427515,0.0004257825,0.01617105,0.01132755,0.005827002,0.01075382,0.0002136443,0.002343709,0.007266481,0.003772539],"study_design_scores_gemma":[0.2179419,0.01328904,0.741515,0.00007953581,0.002996594,0.00007114954,0.002251848,0.01905903,0.0001943959,0.000049663,0.002120396,0.0004313711],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9957247,0.00006775901,0.000004468891,0.000152598,0.000266467,0.001848997,0.00001946624,0.000140582,0.001774958],"genre_scores_gemma":[0.9991407,0.00001689556,0.00006760727,0.0001181061,0.00002281232,0.000167739,0.0001674821,0.00003517935,0.0002635111],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.133036,"threshold_uncertainty_score":0.9936257,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03278476210436797,"score_gpt":0.3275913327918503,"score_spread":0.2948065706874823,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}